NRP1 and breast cancer: There is also evidence showing that FOXP3 suppresses angiogenesis by inhibiting VEGF expression in breast cancer (47), and on T regulatory cells, FOXP3 contributes to immunosuppression in a NRP1-dependent manner (48).